¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fractional sodium excretion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • water excretion
    ¼öºÐ¹è¼³(â©ÝÂÛÉàÜ).
  • water excretion test
    ¼öºÐ¹è¼³½ÃÇè(â©ÝÂÛÉàÜãËúÐ).
  • calcium sodium exchange
    Ä®½·-³ªÆ®·ý ±³È¯(-Îßüµ)
  • exchangeable sodium
    ±³È¯¼º ³ªÆ®·ý
  • exsiccated sodium arsenate<³ª> sodii ar se nas exsiccatus
    °ÇÁ¶ºñ»ê³ªÆ® ·ý.
  • exsiccated sodium phosphate
    °ÇÁ¶Àλê(¡­ìÝß«)³ªÆ®·ý.
  • fluorescein sodium
    Ç÷οÀ·¹½Å ³ªÆ®·ý.
  • hexobarbital sodium
    Çí»ç¹Ù¸£ºñÅ»³ªÆ®·ý.
  • iodophthalein sodium
    °¡¿ë¼º(ʦéÁàõ) ¿äµå ÇÁÅ»·¹ÀÎ.
  • isotonic sodium chloride solution
    »ý¸®½Ä¿°¾×(ßæìµãÝç¤äû), »ý½Ä¼ö(ßæãÝâ©) .
  • low sodium syndrome
    Àú³ªÆ®·ýÁõÈıº(­ñøý¦ÏØ).
  • meralluride sodium
    ¸Þ¶ö·ç¶óÀ̵峪Ʈ·ý.
  • meralluride sodium solution
    ¸Þ¶ö·ç¶óÀ̵峪Ʈ·ýÁÖ»ç¾×(¡­ñ¼ÞÒäû).
  • natrium =sodium
    ³ªÆ®·ý.
  • nonexchangeable sodium
    ºñ±³È¯¼º ³ªÆ®·ý.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AER Albumin Excretion Rate
ADME [drug] absorption, distribution, metabolism, and excretion
CaE calcium excretion
CUE cumulative urinary excretion
excr excretion
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SER Sebum Excretion Rate
UAE Urinary Albumin Excretion
UAE Urinary albumin excretion rate
UAER Urinary albumin excretion rate
UIE Urinary iodine excretion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sodium fluoride denitifrice
    ºÒÈ­ ³ªÆ®·ý Ä¡¾à
  • sodium glutamate
    ±Û·çŸ¹Î»ê ³ªÆ®·ý
    ¾Æ¹Ì³ë»êÀÇ ÇϳªÀÎ L-±Û·çŸ¹Î»êÀÇ ³ªÆ®·ý¿°. ÁÁÀº ¸ÀÀ» Áö³à Á¶¹Ì·á·Î¼­ Àß ¾Ë·ÁÁ® ÀÖ´Ù. D-ü´Â Ưº°ÇÑ ¸ÀÀ» Áö´Ï°í ÀÖÁö ¾Ê´Ù. l-±Û·çŸ¹Î»êÀº ³ú ´ë»ç¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç ¾Ï¸ð´Ï¾Æ¿Í °áÇÕÇØ ±Û·çŸ¹ÎÀÌ µÇ¹Ç·Î ÀúÇ÷´ç È¥¼ö, °£¼º È¥¼ö ½Ã³ª ¾Ï¸ð´Ï¾Æ ÇØµ¶¿¡ »ç¿ëÇÑ´Ù. ´Ù·® »ç¿ë ½Ã¿¡´Â ¾ËÄ®·Î½Ã½º, ¿À½É, ±¸Åä, µÎºÎ ¾Ð¹Ú°¨, µÎÅë µîÀÌ ³ªÅ¸³ª´Â ¼ö°¡ ÀÖ´Ù. À̰ÍÀº Á¶¹Ì·á¸¦ ´Ù·® »ç¿ëÇÏ´Â ÁßÈ­ ¿ä¸®¸¦ ¸ÔÀº µÚ¿¡ ÀϾ´Â Á¡¿¡¼­ ÁßÈ­ ¿ä¸®Á¡ ÁõÈıº
  • sodium hydroxide
    ¼ö»êÈ­ ³ªÆ®·ý
    ¹é»öÀÇ °íü. ÀÛ°í µÕ±Ù ¸ð¾ç, ¹ÚÆí ¸ð¾ç, ¸·´ë ¸ð¾ç µî ¿©·¯ ¸ð¾çÀ¸·Î Á¸ÀçÇÑ´Ù. °­ÇÑ ¾ËÄ®¸®¼º. Á¦¾×¿¡¼­ ¾ËÄ®¸®È­Á¦·Î »ç¿ëÇÑ´Ù.
  • sodium hypochlorite
    Â÷¾Æ¿°¼Ò»ê ³ªÆ®·ý
  • sodium lauryl sulfate
    ¶ó¿ì¸± Ȳ»ê ³ªÆ®·ý
    À½À̿ ǥ¸é Ȱ¼ºÁ¦. ¹é»ö ¶Ç´Â ¹àÀº Ȳ»öÀÇ °áÁ¤. ½ÀÀ±Á¦, À¯È­ º¸Á¶Á¦, °¢Á¾ ¹Ì¿ë°ú ÇǺο¡ ´ëÇÑ ¼¼Á¤Á¦, Å©¸² Ä¡¾àÀÇ ¼ººÐÀ¸·Î »ç¿ëÇÑ´Ù.
  • sodium monofluorophosphate
    ÀÏ ºÒ¼Ò ÀÎ»ê ³ªÆ®·ý
    µ¿ÀǾî=
  • sodium nitrate
    ¾ÆÁú»ê ³ªÆ®·ý
    ¹é»öÀ̳ª ¾à°£ ³ë¶õ»öÀÇ °ú¸³¼º ºÐ¸», ¹é»öÀÇ ºÒÅõ¸íÇÑ ¿ëÀ¶ µ¢¾î¸® ¶Ç´Â ¸·´ë ¸ð¾ç. û»ê Ä®¸® Áßµ¶¿¡ ´ëÇÑ ÇØµ¶Á¦·Î »ç¿ëÇÑ´Ù. Çù½ÉÁõ, õ½ÄÀÇ °æ¿ì¿¡µµ »ç¿ëµÇ¸ç, º¹Åë, °æ·Ã¼º ´ëÀå¿°°ú °°Àº »óÅ¿¡µµ ÀÌ¿ëµÇ°í ÀÖ´Ù.
  • sodium perborate
    °úºØ»ê ³ªÆ®·ý
    ºØ»êÀ̳ª ºØ»ê³ªÆ®·ýÀÌ ³ªÆ®·ý ¶Ç´Â °ú»êÈ­ ¼ö¼Ò¿Í »óÈ£ÀÛ¿ëÇÏ¿© »ý¼ºµÈ È­ÇÕ¹°, ¹æºÎÁ¦. 2% ¿ë¾×À¸·Î´Â ¾çÄ¡Áú ¾×À¸·Îµµ »ç¿ëµÈ´Ù.
  • sodium phosphate
    ÀÎ»ê ³ªÆ®·ý
    µ¿ÀǾî=disodium hydrogen
  • sodium polystyrene sulfonate
    Æú¸®½ºÅ¸À̸° ¼³Æù ³ªÆ®·ý
    ³ªÆ®·ý ÇüÅÂÀÇ ¾çÀ̿ ±³È¯ ¼öÁö 1g´ç ¹«¼ö±âÀÇ Ä®·ý 110-135mg °ú ±³È¯. °úÄ®·ý Ç÷Áß Ä¡·á¿¡ »ç¿ëÇÑ´Ù.
  • sodium pump
    ³ªÆ®·ý ÆßÇÁ
  • sodium salicylate
    »ì¸®½Ç»ê ³ªÆ®·ý
    ¹«Á¤ÇüÀÇ °áÁ¤¼º ºÐ¸» ¶Ç´Â Àμ³·Î¼­ Á¸ÀçÇÑ´Ù. ÁøÅëÁ¦, ÇØ¿­Á¦, Ç×°üÀý¿°Á¦·Î »ç¿ëµÇ¸ç °æ±¸ÀûÀ¸·Î Åõ¿©µÈ´Ù.
  • sodium sulfate
    Ȳ»ê ³ªÆ®·ý
    ¹Ù·ý Áßµ¶¿¡ ´ëÇÑ ÇØµ¶Á¦ ¼³»ç ¾àÀ¸·Î »ç¿ëÇϸç, °¨¿°µÈ »óó¿¡ ´ëÇÑ ÃÖ¸²ÇÁ ¾àÀ¸·Î¼­ ±¹¼ÒÀûÀ¸·Î »ç¿ëÇϱ⵵ ÇÑ´Ù.
  • sodium tertiary phosphate
    Á¦ 3ÀÎ »ê³ªÆ®·ý
    Ca3
  • sodium tetradecyl sulfate
    Åׯ®¶óµ¥½ÇȲ»ê³ªÆ®·ý
    °æÈ­¼ºÀ» °®´Â À½À̿ °è¸éȰ¼ºÁ¦, ¹é»öÀÇ ¹Ð¶ø¼º °íü. ½ÀÀ±Á¦·Î¼­ ¾²À̸ç, Á¤¸Æ·ù¿Í Ä¡ÁúÀÇ Ä¡·á·Îµµ »ç¿ëÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
gold sodium thiomalate <chemical> A variable mixture of the mono- and disodium salts of gold thiomalic acid used mainly for its anti-inflammatory action in the treatment of rheumatoid arthritis. It is most effective in active progressive rheumatoid arthritis and of little or no value in the presence of extensive deformities or in the treatment of other forms of arthritis.
Pharmacological action: antirheumatic agents, gold.
Chemical name: Butanedioic acid, mercapto-, monogold(1+) sodium salt
(12 Dec 1998)
gold sodium thiosulfate <chemical> An antirheumatic agent with the same actions and uses as gold sodium thiomalate.
Pharmacological action: antirheumatic agents, gold.
Chemical name: Aurate(3-), bis(monothiosulfato(2-)-O,S)-, trisodium, (T-4)-
(12 Dec 1998)
menadiol sodium diphosphate Tetrasodium 2-methyl-1,4-naphthalenediol-bis(dihydrogen phosphate);a dihydro derivative of menadione, with similar vitamin K activity.
(05 Mar 2000)
menadione sodium bisulfite It possesses the same action and is used for the same purposes as menadione or vitamin K; it differs, however, from menadione in being water-soluble.
(05 Mar 2000)
mercaptomerin sodium N-(gamma-Carboxymethylmercaptomercuri-beta-methoxy)propylcamphoramic acid disodium salt;a mercurial diuretic.
(05 Mar 2000)
mercurophylline sodium The sodium salt of beta-methoxy-gamma-hydroxymercuripropylamide of trimethylcyclopentanedicarboxylic acid, and theophylline; a mercurial diuretic.
(05 Mar 2000)
chloramphenicol sodium succinate <chemical> Chloramphenicol-alpha-(sodium succinate);the water-soluble sodium succinate derivative of chloramphenicol, suitable for parenteral administration; antibacterial activity, uses, and side effects are similar to those of the parent compound.
(05 Mar 2000)
cholistine sulphomethate sodium Pentasodium colistinmethanesulfonate;contains the pentasodium salt of the penta(methanesulfonic acid) derivative of colistin A as the major component, with a small proportion of the pentasodium salt of the same derivative of colistin B; an effective antibiotic against most Gram-negative bacilli (except Proteus), given intramuscularly.
See: colistin sulfate, polymyxin.
Synonym: cholistine sulphomethate sodium, colistin sulfomethate sodium.
(05 Mar 2000)
methicillin sodium Sodium 2,6-dimethoxyphenylpenicillin monohydrate;a semisynthetic penicillin salt for parenteral administration; restriction of its use to infections caused by penicillin G-resistant staphylococci is recommended; it is less effective than penicillin G in infections caused by haemolytic streptococci, pneumococci, gonococci, and penicillin G-sensitive staphylococci.
Synonym: sodium methicillin.
(05 Mar 2000)
methiodal sodium An iodine-containing radiopaque medium, formerly used for examination of the urinary tract.
(05 Mar 2000)
methohexital sodium Sodium alpha-dl-methyl-5-allyl-5-(1-methyl-2-pentynyl)barbiturate;an ultrashort-acting barbiturate used intravenously for induction and for general anaesthesia of short duration.
(05 Mar 2000)
metrizoate sodium Sodium 3-acetamido-5-(N-methylacetamido)-2,4,6-triiodobenzoate;a diagnostic radiopaque medium.
Synonym: metrizamide.
(05 Mar 2000)
mezlocillin sodium <drug> an extended spectrum penicillin antibiotic used intravenously and intramuscularly.
Structure: C21H24NaN5O8S2
(21 Jun 2000)
cilastatin sodium C16H25N2NaO5S;an inhibitor of the renal dipeptidase, dehydropeptidase 1, used, in conjunction with antibiotics subject to metabolism in the kidneys, to increase therapeutic response to the antibiotic.
(05 Mar 2000)
cloxacillin sodium <drug> A penicillinase-resistant penicillin.
Chemical name: [5-Methyl-3-(o-chlorophenyl)-4-isoxazolyl]penicillin sodium
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á